FDA Promises Interchangeability For Alvotech’s 100mg/ml Humira Rival – If It Passes Inspection

Alvotech has been bolstered by a US FDA confirmation that its AVT02 adalimumab candidate can be approved as an interchangeable biosimilar based on the data provided in its filing – but first, the Icelandic firm must pass an upcoming facility inspection.